IVA Inventiva S.A. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
16:52
Jul 27
Jul 27
Adding to existing long IVA position; author characterizes it as a high-upside bet and plans to increase exposure imminently.
MED
00:07
Jul 27
Jul 27
The author is highly confident in biotech timing, recommending XBI as a bottom and naming RVMD, ABVX, TENX, and NKTR as high-conviction longs with specific catalysts and price targets.
18:41
Jul 20
Jul 20
Buy as Phase 3 replication of Phase 2 plus BP acquisition precedent in MASH supports upside.
MED
14:07
Jul 15
Jul 15
Author discloses existing long position in IVA, expressing desire for larger exposure within the broader XBI bullish thesis of macro tailwinds and record sector M&A.
MED
20:04
Jul 10
Jul 10
Long IVA on Phase 2 data readout expected to translate positively, in a space with established large biopharma M&A interest.
MED
About IVA Analyst Coverage
Buzzberg tracks IVA (Inventiva S.A.) across 1 sources. 3 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (60%). 5 total trade ideas tracked. Past 7 days: 1 bullish, 1 watch. Latest voices: seedy19tron.